Menu Search
Equities

Silence Therapeutics PLC

XRP2:STU

Silence Therapeutics PLC

Actions
  • Price (EUR)15.60
  • Today's Change-0.300 / -1.89%
  • Shares traded0.00
  • 1 Year change+75.28%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Silence Therapeutics PLC had net income fall 6.86% from a loss of 40.49m to a larger loss of 43.27m despite a 44.99% increase in revenues from 17.50m to 25.38m.
Gross margin56.40%
Net profit margin-224.01%
Operating margin-270.81%
Return on assets-28.51%
Return on equity-64.28%
Return on investment-32.89%
More ▼

Cash flow in GBPView more

In 2023, Silence Therapeutics PLC did not generate a significant amount of cash. Cash Flow from Financing totalled 25.16m or 99.13% of revenues. In addition the company used 39.35m for operations while cash from investing totalled 16.43m.
Cash flow per share-1.23
Price/Cash flow per share--
Book value per share3.11
Tangible book value per share2.89
More ▼

Balance sheet in GBPView more

Silence Therapeutics PLC uses little debt in its capital structure as supported by a debt to capital ratio of 0.16%.
Current ratio9.83
Quick ratio--
Total debt/total equity0.0016
Total debt/total capital0.0016
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.